Kinesiotaping vs. NSAIDs plus physical therapy in treatment of pes anserine bursitis

Study Type: Therapy
OE Level of Evidence: 2
Journal Level of Evidence: N/A
Synopsis
56 patients with pes anserinus tendino-bursitis were randomized to two treatment groups: one group received 3 weeks of kinesiotaping, while the other received 10 days of naproxen 250mg three times daily plus daily physical therapy sessions. The purpose of this study was to compare pain, swelling, and adverse events from pre- to post-treatment. Results demonstrated a Please login to view the rest of this report. Please login to view the rest of this report.
Funding: Not Reported
Conflicts: None disclosed
CONTENT IS LOCKED
Why was this study needed now?
There is a lack of evidence evaluating treatments for pes anserinus tendino-bursitis. Kinesiotape is novel treatment modality which has been proposed to relax muscles, reduce pain, and reduce swelling. High-quality research is needed to evaluate the efficacy of kinesiotape in the management of pes anserinus tendino-bursitis to guide recommendations for use.
What was the principal research question?
In the treatment of pes anserinus tendino-bursitis, is there any significant difference in pain scores, ultrasound-assessed swelling, and adverse events between kinesiotaping and naproxen combined with physical therapy?
Population: 56 patients, 20-70 years of age, with clinically diagnosed pes anserinus tendino-bursitis and symptoms lasting for a minimum of 3 months.
Intervention: KT group: Participants received kinesiotape with a space-correction technique by lifting the skin away from the affected area of the knee. Kinesiotape was provided for 3 weeks, with reapplication at 1-week intervals. (n=28; 27 analyzed) (Mean age: 49.85+/-6.8)
Comparison: NSAID plus PT group: Participants were prescribed naproxen 250mg three times daily for 10 days. Participants also performed a total of 10 daily physical therapy sessions, including the use of hot packs, transcutaneous electrical nerve stimulation, and phonophoresis. (n=28; 19 analyzed) (Mean age: 50.0+/-6.6)
Outcomes: Primary outcomes were pain on a visual analog scale, and depth of swelling measured using ultrasonography. Swelling was graded on a 1-3 scale, with 1 as <0.5cm, 2 as 0.5-1.0cm, and 3 as >1cm. The secondary outcome was the incidence of adverse events.
Methods: RCT
Time: Follow-up was performed at the end of the treatment phase.
What were the important findings?
What should I remember most?
How will this affect the care of my patients?
The authors responsible for this critical appraisal and ACE Report indicate no potential conflicts of interest relating to the content in the original publication.